133 related articles for article (PubMed ID: 32882607)
1. Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as α7 nicotinic receptor antagonists.
Zhang H; He X; Wang X; Yu B; Zhao S; Jiao P; Jin H; Liu Z; Wang K; Zhang L; Zhang L
Eur J Med Chem; 2020 Dec; 207():112774. PubMed ID: 32882607
[TBL] [Abstract][Full Text] [Related]
2. N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists.
Criado M; Mulet J; Sala F; Sala S; Colmena I; Gandía L; Bautista-Aguilera OM; Samadi A; Chioua M; Marco-Contelles J
ACS Chem Neurosci; 2016 Aug; 7(8):1157-65. PubMed ID: 27254782
[TBL] [Abstract][Full Text] [Related]
3. New quinoline derivatives as nicotinic receptor modulators.
Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
[TBL] [Abstract][Full Text] [Related]
4. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
[TBL] [Abstract][Full Text] [Related]
5. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
Peng W; Ding F
Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
[TBL] [Abstract][Full Text] [Related]
6. N
Alwassil OI; Khatri S; Schulte MK; Aripaka SS; Mikkelsen JD; Dukat M
ACS Chem Neurosci; 2021 Jun; 12(12):2194-2201. PubMed ID: 34043311
[TBL] [Abstract][Full Text] [Related]
7. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library.
Chang YP; Banerjee J; Dowell C; Wu J; Gyanda R; Houghten RA; Toll L; McIntosh JM; Armishaw CJ
J Med Chem; 2014 Apr; 57(8):3511-21. PubMed ID: 24649848
[TBL] [Abstract][Full Text] [Related]
9. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue inhibits the function of α7-nicotinic acetylcholine receptors.
Al Mansouri AS; Lorke DE; Nurulain SM; Ashoor A; Keun-Hang SY; Petroianu G; Isaev D; Oz M
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):791-800. PubMed ID: 22483305
[TBL] [Abstract][Full Text] [Related]
12. Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation.
Xue Y; He X; Yang T; Wang Y; Liu Z; Zhang G; Wang Y; Wang K; Zhang L; Zhang L
Eur J Med Chem; 2019 Nov; 182():111618. PubMed ID: 31434041
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent α-Conotoxin [Q1G, ΔR14]LvIB Identifies the Distribution of
Shan H; Wang N; Gao X; Wang Z; Yu J; Zhangsun D; Zhu X; Luo S
Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786593
[No Abstract] [Full Text] [Related]
14. Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.
Zaveri N; Jiang F; Olsen C; Polgar W; Toll L
J Med Chem; 2010 Nov; 53(22):8187-91. PubMed ID: 20979364
[TBL] [Abstract][Full Text] [Related]
15. Di- and heptavalent nicotinic analogues to interfere with α7 nicotinic acetylcholine receptors.
Brissonnet Y; Araoz R; Sousa R; Percevault L; Brument S; Deniaud D; Servent D; Le Questel JY; Lebreton J; Gouin SG
Bioorg Med Chem; 2019 Mar; 27(5):700-707. PubMed ID: 30692022
[TBL] [Abstract][Full Text] [Related]
16. α-Conotoxin as Potential to α7-nAChR Recombinant Expressed in
Liu Y; Yin Y; Song Y; Wang K; Wu F; Jiang H
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32806654
[TBL] [Abstract][Full Text] [Related]
17. Species specificity of rat and human α7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists.
Yu J; Zhu X; Zhang L; Kudryavtsev D; Kasheverov I; Lei Y; Zhangsun D; Tsetlin V; Luo S
Neuropharmacology; 2018 Sep; 139():226-237. PubMed ID: 30025921
[TBL] [Abstract][Full Text] [Related]
18. Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B.
Tang JS; Xie BX; Bian XL; Xue Y; Wei NN; Zhou JH; Hao YC; Li G; Zhang LR; Wang KW
Acta Pharmacol Sin; 2015 Jul; 36(7):800-12. PubMed ID: 25948478
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of αM-conotoxin SIIID, a reversible human α7 nicotinic acetylcholine receptor antagonist.
Wang H; Li Y; Yang M; Zhou M
Toxicon; 2022 Apr; 210():141-147. PubMed ID: 35255330
[TBL] [Abstract][Full Text] [Related]
20. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
